The SAGE Encyclopedia of Stem Cell Research. Группа авторов

The SAGE Encyclopedia of Stem Cell Research - Группа авторов


Скачать книгу
(Accessed April 2014).

      Anker, P. S. In’t, S. A. Scherjon, C. Kleijburg-Van Der Keur, et al. “Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin From Human Placenta.” Stem Cells, v.22/7 (2004).

      Govtrack.US. https://www.govtrack.us/congress/bills/110/hr1892 (Accessed March 2014).

      Lai, D., F. Wang, Y. Chen, et al. “Human Amniotic Fluid Stem Cells Have a Potential to Recover Ovarian Function in Mice With Chemotherapy-Induced Sterility.” BMC Developmental Biology, v.13/34 (2013).

      Mosquera, A., J. L. Fernandez, A. Campos, et al. “Simultaneous Decrease of Telomere Length and Telomerase Activity With Ageing of Human Amniotic Fluid Cells.” Journal of Medical Genetics, v.36 (1999).

      National Council of State Legislatures. (2008). http://www.ncsl.org/research/health/embryonic-and-fetal-research-laws.aspx (Accessed April 2014).

      PLOS.org. “Cloned, CD117 Selected Human Amniotic Fluid Stem Cells Are Capable of Modulating the Immune Response.” http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0026535#citedHeader (Accessed April 2014).

      Prasongchean, W., M. Bagni, C. Calzarossa, et al. “Amniotic Fluid Stem Cells Increase Embryo Survival Following Injury.” Stem Cells and Development, v.21/5 (2012).

      Torricelli, F., L. Brizzi, P. A. Bernabei, et al. “Identification of Hematopoietic Progenitor Cells in Human Amniotic Fluid Before the 12th Week of Gestation.” Italian Journal of Anatomic Embryology, v.98 (1993).

      U.S. National Library of Medicine. “Amniocentesis.” http://www.nlm.nih.gov/medlineplus/ency/article/003921.htm (Accessed March 2014).

      Zani, Augusto, Mara Cananzi, Francesco Fascetti-Leon, et al. “Amniotic Fluid Stem Cells Improve Survival and Enhance Repair of Damaged Intestine in Necrotising Enterocolitis via a COX-2 Dependent Mechanism.” Gut, v.63/2 (2013).

      Animal Cloning

      Animal Cloning

      46

      48

      Animal Cloning

      In biology, the term cloning refers to the process of producing genetically identical individuals. Cloning is the practice of separating a group of cells or cell derivates so that each produces only an identical copy of its type. This process occurs naturally in organisms that reproduce asexually, such as plants, insects, and bacteria. The practice of cloning has long historical roots, as it has been a common part of the human experience for thousands of years; for example, growing a plant from a cutting is an early type of cloning. The more recent history of experimental cloning of animals that do not normally reproduce asexually dates back to the early 1900s, when scientist Hans Spemann split an early salamander embryo into two parts, which then developed into two full and distinct organisms. This proved that embryonic cells carry all the genetic information required to develop into a new organism. However, cloning of advanced animals had not been considered possible until the successful cloning of the first mammal, a sheep called Dolly, in 1997. The cloning of Dolly was a momentous scientific and technological development; it also opened the door to the possibility of human cloning, and with it, myriad related medical issues and ethical concerns. Many other mammals, from rodents to cows, have since been successfully cloned.

      During the 1970s, cells of two separate embryos of different strains of mice were joined at an early stage of development, in order to produce a single chimeric embryo that later developed into adult mice, which exhibited characteristics of both strains. Progress in the experimental manipulation of mammalian embryos has led to the development of cutting-edge techniques for the production of genetically modified animals. Injection of cloned DNA into the pronuclei of fertilized one-cell eggs allows the production of a transgenic animal with a foreign gene that has been deliberately inserted into its genome. The foreign gene is generally constructed using recombinant DNA technologies. In addition to a structural gene that will code for an RNA or protein product, the recombinant DNA usually includes other sequences in order to be expressed correctly in the host cells. Other important techniques were developed later, such as retrovirus-mediated transgenesis and embryonic stem cell–mediated gene transfer, which is based on the creation of chimeric embryos.

      The technology to produce transgenic and cloned animals often have overlapping goals but they produce different types of animals. Transgenic commonly refers to an animal or plant that contains one or more genes from another organism, incorporated into its own genome. It is capable of passing on the foreign genes to its offspring. A cloned animal, however, is an organism that is genetically identical to its progenitor. Cloning remains a topic of deeply complex scientific and ethical issues. The potential for cloning to cure disease, to increase and better the food supply worldwide, and to save and recover endangered species are at the forefront of issues hotly debated today. Animal cloning has application to the medical and pharmaceutical industries, to the food industries and lately, to the pet cloning industry too. The topic of cloning today continues to have profound scientific, ethical, economic, political, and religious repercussions.

      Main Fields of Impact of Animal Cloning Technology

      Deoxyribonucleic acid, or DNA, is a self-replicating polymer present in most live organisms. It contains all of the information necessary for the development of live beings. The term DNA cloning, as well as molecular cloning, recombinant DNA technology, and gene cloning, refer to a set of methods that transfer DNA from one organism to a self-replicating genetic element such as a bacterial plasmid or a virus. The DNA is then taken from the plasmid and propagated in a foreign host cell. This technology, developed in the 1970s, is commonplace in molecular biology laboratories today.

      Reproductive cloning is a technology used to generate an animal that has the same nuclear DNA as another currently or previously existing animal. Scientist Ian Wilmut and his team deeply revolutionized the scientific world at large in 1997 when they created Dolly, a sheep cloned from a mammary cell. Cloning today is used to, among other things, produce stem cells that offer the possibility of more effective medical treatments than ever before. Dolly’s birth also caused widespread concern about the eventual possibility of cloning human beings, a possibility strongly opposed by the creators of this technology. Even though they opposed cloning of the human species, however, scientists who created the first cloned mammal argued that science should eventually be allowed to combine the technologies of cloning human embryos with that of genetic modification. This could allow science to discover cures for people suffering from serious hereditary diseases. On the other hand, others have argued that this would mean the creation of genetically altered humans.

      Dolly was created by reproductive cloning technology through a process known as somatic cell nuclear transfer. In order to produce Dolly, the scientific team used the nucleus extracted from an udder of an adult Finn Dorset white sheep. Most of a cell’s genes are held in the nucleus of a cell. Scientists had to figure out how to reprogram the cells, that is, to keep the cells alive while at the same time, stopping their growth. They achieved this by making changes in the growth medium and injecting the cell into a Blackface sheep’s unfertilized egg cell, from which the nucleus had been previously removed. Afterward, the cells were fused through electrical pulses. Once scientists had fused the nucleus from the white sheep cell with the egg cell from the black-faced sheep, they cultured it for approximately a week to ensure that it divided and developed properly, before implanting it into the uterus of a surrogate mother, another Blackface sheep. Dolly, however, was born with a white face. In order to achieve Dolly’s birth, the researchers had produced close to 300 cell fusions, from which 29 embryos resulted. These were subsequently implanted into 13 surrogate mothers. Only the pregnancy


Скачать книгу